Cell Biotech Co., Ltd · KRX:049960

Cell Biotech — Q1 2024 Earnings Presentation

8 slides from Cell Biotech's earnings presentation, 2024

  1. Slide 1: Cell Biotech - Probiotics & Microbiome company

    CELL BIOTECH Probiotics & Microbiome company 1

  2. Slide 2: Revenue up 1.5% to KRW 13.0 billion, operating profit up 2.9%

    CELL BIOTECH Revenue up 1.5% to KRW 13.0 billion, operating profit up 2.9% to KRW 1.1 billion Domestic revenue down 12.2%, overseas revenue up 20.2% Duolac brand sales down 14.5% to KRW 6.6 billion, OEM/ODM sales up 37.1% to KRW 5.2 billion, Raw material sales dawn 8% to KRW 1.2 billion (unit : KRW

  3. Slide 3: Quarterly revenue and full year revenue

    CELL BIOTECH 1q revenue KRW 13.0 billion, yoy +1.5%, qoq -12.2% Quarterly revenue Full year revenue (unit: KRW mil) (unit : KRW mil) 53,787 50,526 46,873 3

  4. Slide 4: Quarterly profit and full year profit

    CELL BIOTECH 1q operating profit KRW 1.1 billion, yoy +2.9% Net Profit KRW +3.3 bil. Quarterly profit Full year profit (unit: KRW mil) (unit: KRW mil) 4

  5. Slide 5: Q1 revenue by Duolac brand, OEM/ODM and raw material

    CELL BIOTECH 1q revenue of Duolac brand -14.5% to 6.6 KRW bil., OEM/ODM +37.1% to 5.2 KRW bil., and raw material -8% to 1.2 KRW bil. (unit : KRW mil) 15,000 13,000 11,000 9,000 7,000 5,000 3,000 '21.2Q '21.3Q '21.4Q '22.1Q '22.2Q '22.3Q '22.4Q 23.1Q 23.2Q 23.3Q 23.4Q 24.1Q2 Duolac-domestic Duolac-ov

  6. Slide 6: Microbiome R&D

    CELL BIOTECH Microbiome R&D No. 1 in global export for 10 consecutive years 1) Microbiome First-in-Class anticancer pipeline ‘PP-P8’ 1) CellBiotech’s lactic acid bacteria ‘Duolac’ ranked clinical phase 1 IND submitted (Mar 5, 2021) No. 1 in global expert for 10 consecutive years. 2) Acquisition Euro

  7. Slide 7: FDA GRAS World's Most Listed

    CELL BIOTECH FDA GRAS World’s Most Listed https://www.hankyung.com/article/202402222016i https://www.dailypharm.com/Users/News/NewsVie w.html?ID=309331&REFERER=NP 7

  8. Slide 8: Income statement and statement of financial position

    CELL BIOTECH Income statement (unit : KRW 100 mil., %) Statement of financial position (unit : KRW 100 mil., %) 8

Cell Biotech — Q1 2024 Earnings Presentation on 6ix